Insulin glargine and lixisenatide Subcutaneous and Timentin Add-Vantage
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Timentin Add-Vantage and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: clavulanate / ticarcillin
Brand name: Timentin
Synonyms: Timentin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Timentin Injection
- Insulin glargine and lixisenatide Subcutaneous-Timentin Novaplus
- Insulin glargine and lixisenatide Subcutaneous-Timolide
- Insulin glargine and lixisenatide Subcutaneous-Timolol
- Insulin glargine and lixisenatide Subcutaneous-Timolol (Systemic)
- Insulin glargine and lixisenatide Subcutaneous-Timolol and hydrochlorothiazide
- Timentin Add-Vantage-Insulin glargine, recombinant Subcutaneous
- Timentin Add-Vantage-Insulin glulisine
- Timentin Add-Vantage-Insulin Glulisine (Cartridges and Pens)
- Timentin Add-Vantage-Insulin Glulisine (Vials)
- Timentin Add-Vantage-Insulin glulisine Subcutaneous
- Timentin Add-Vantage-Insulin human inhaled Inhalation